Understanding how small molecules interact with their protein targets, and importantly, their off-targets, is one of the biggest challenges in drug discovery.

Take a 2-minute virtual site tour through the Eurofins DiscoverX San Francisco Bay Area (Fremont, California) laboratories. Learn about our key capabilities and meet our amazing employees.

Eurofins Discovery, a leading provider of products and services that support Pharma and Biotech to advance drug discovery and development, today announced a sponsorship agreement with Bayer Co.Lab Cambridge, Bayer’s premier life sciences incubator located in Kendall Square, Massachusetts.

Since the first FDA approval in 2000, the antibody-drug conjugate (ADC) pipeline has grown extensively, with more than 100 ADCs in active clinical trials and many more in preclinical development.

GPCR Signaling Bias ON DEMAND Webinar. A Valuable & Accessible Property of New Drug Candidates. Presented by Terry Kenakin, Ph.D., Prof. of Pharmacology, U. N. Carolina, School of Medicine, Chapel Hill, NC, USA. This webinar explains the biological basis of signaling bias, shows how to detect and quantify it using reliable functional assays, and discusses how these data can guide lead selection and optimization. Practical assay strategies, interpretation pitfalls, and the value of comparing pathway outputs quantitatively, rather than relying on potency alone, sit at the center of the session.